Tech Center 1600 • Art Units: 1633
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18011704 | ENGINEERED REPRODUCTIVE ISOLATION IN ANIMALS | Final Rejection | The Regents of the University of California |
| 18006900 | CANINE AND FELINE INDUCIBLE EXPRESSION CONSTRUCTS FOR GENE THERAPY APPLICATIONS | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18028180 | IMMORTALIZED KERATINOCYTES, LENTIVIRUS FOR KERATINOCYTE IMMORTALIZATION, AND METHODS OF USE | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17797633 | METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS | Final Rejection | ASKBIO INC. |
| 18250996 | PSEUDOTYPED PARTICLES, MODIFIED CELLS, RELATED COMPOSITIONS, AND RELATED METHODS | Non-Final OA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| 18501627 | COMPOSITION AND METHODS FOR INDUCING MYELOID SUPPRESSIVE CELLS AND USE THEREOF | Non-Final OA | Fate Therapeutics, Inc. |
| 18351561 | THREE-DIMENSIONAL CULTURE SYSTEM FOR GENERATING CARDIAC SPHEROIDS | Non-Final OA | THE UAB RESEARCH FOUNDATION |
| 17907187 | MUSCLE TISSUE PRODUCED BY BIOPRINTING | Final Rejection | OSAKA UNIVERSITY |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | Final Rejection | St. Jude Children's Research Hospital, Inc. |
| 17759308 | METHOD FOR MANUFACTURING INDUCED PLURIPOTENT STEM CELLS | Non-Final OA | Koji TANABE |
| 17267699 | Expansion of TILs from Cryopreserved Tumor Samples | Final Rejection | Iovance Biotherapeutics, Inc. |
| 18409015 | PREPARATION METHOD AND USE OF HYDROGEL MATERIAL FOR GROWTH OF BLOOD VESSEL ORGANOIDS | Non-Final OA | Union Hospital Tongji Medical College HUST |
| 17743069 | COMPOSITIONS AND METHODS OF REPROGRAMMING T CELLS TO TREAT DISEASE | Non-Final OA | MedicaMetrix, Inc. |
| 18570823 | UMBILICAL CORD BLOOD MONONUCLEAR CELLS AND RED CELL FRACTION IMPROVE NEUROGENESIS AND BEHAVIORAL RECOVERY AFTER HYPOXIA-ISCHEMIC BRAIN DAMAGE | Non-Final OA | MONONUCLEAR THERAPEUTICS LIMITED |
| 18551317 | METHOD FOR PRODUCING CULTURE CELLS REQUIRING A SUPPLY OF FERRIC IRON | Non-Final OA | Safi Biotherapeutics, Inc. |
| 18271112 | MEDIUM FOR CULTURING AND EXPANDING NEPHRON PROGENITOR CELLS, METHOD FOR CULTURING AND EXPANDING NEPHRON PROGENITOR CELLS, AND METHOD FOR PRODUCING RENAL ORGANOIDS | Non-Final OA | Rege Nephro Co., Ltd. |
| 17909113 | GENE THERAPY | Final Rejection | THE UNIVERSITY OF BRISTOL |
| 17924811 | DUAL PROMOTER SYSTEMS | Non-Final OA | Seattle Children's Hospital (dba Seattle Children's Research Institute) |
| 17973358 | CELL CULTURE FEEDING DEVICE | Final Rejection | Regenerative Research Foundation |
| 17926709 | VECTORS ENCODING A GLUCOSE-6-PHOSPHATASE (G6PASE-A) FOR GENE THERAPY | Final Rejection | UNIVERSITE CLAUDE BERNARD LYON 1 |
| 18027250 | COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION | Non-Final OA | Seelos Therapeutics, Inc. |
| 17920711 | GENE EDITING OF LRRK2 IN STEM CELLS AND METHOD OF USE OF CELLS DIFFERENTIATED THEREFROM | Non-Final OA | Aspen Neuroscience, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy